Thromboembolic risk rises without anticoagulants after cardioversion

07/19/2013 | Healio

A 5,116-participant study found that patients who are at risk of thromboembolism are more likely to suffer thromboembolic events if they are not treated with anticoagulants following cardioversion of acute atrial fibrillation. The results affirm the European Society of Cardiology's 2010 recommendation that acute AF patients receive anticoagulants, specifically heparin peri-cardioversion followed by long-term use of a vitamin K antagonist during and after restoration of normal heart rhythm.

View Full Article in:

Healio

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX